Dr.med. ID: 1926843

Susanne Burdak-Rothkamm

graph of relations

Publications

  1. 2023
  2. Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease

    Elsesy, M. E., Oh-Hohenhorst, S. J., Oing, C., Eckhardt, A., Burdak-Rothkamm, S., Alawi, M., Müller, C., Schüller, U., Maurer, T., von Amsberg, G., Petersen, C., Rothkamm, K. & Mansour, W. Y., 06.2023, In: MOL ONCOL. 17, 6, p. 1129-1147 19 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2022
  4. Monitoring very low dose radiation damage in DNA using "field-friendly" biomarkers

    Rothkamm, K. & Burdak-Rothkamm, S., 2022, Biomarkers of Radiation in the Environment: Robust Tools for Risk Assessment. Wood, M. D., Mothersill, C. E., Tsakanova, G., Cresswell, T. & Woloschak, G. E. (eds.). 1 ed. Dordrecht: Springer, p. 137-151 15 p. (NATO Science for Peace and Security Series A: Chemistry and Biology book series (NAPSA)).

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  5. 2021
  6. Interplay between DNA replication stress, chromatin dynamics and DNA-damage response for the maintenance of genome stability

    Mognato, M., Burdak-Rothkamm, S. & Rothkamm, K., 05.06.2021, In: MUTAT RES-REV MUTAT. 787, 108346.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  7. DNA Damage Repair Deficiency and Synthetic Lethality for Cancer Treatment

    Burdak-Rothkamm, S. & Rothkamm, K., 01.2021, In: TRENDS MOL MED. 27, 1, p. 91-92 2 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  8. 2020
  9. Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-rays

    Rothkamm, K., Christiansen, S., Rieckmann, T., Horn, M., Frenzel, T., Brinker, A., Schumacher, U., Stein, A., Petersen, C. & Burdak-Rothkamm, S., 28.11.2020, In: CANCER LETT. 493, p. 179-188 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. DNA Damage Repair Deficiency in Prostate Cancer

    Burdak-Rothkamm, S., Mansour, W. Y. & Rothkamm, K., 11.2020, In: TRENDS CANCER. 6, 11, p. 974-984 11 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  11. Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair

    Elsesy, M. E., Oh-Hohenhorst, S. J., Löser, A., Oing, C., Mutiara, S., Köcher, S., Meien, S., Zielinski, A., Burdak-Rothkamm, S., Tilki, D., Huland, H., Schwarz, R., Petersen, C., Bokemeyer, C., Rothkamm, K. & Mansour, W. Y., 31.08.2020, In: CANCERS. 12, 9

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. 2019
  13. A functional ex vivo assay to detect PARP1-EJ repair and radiosensitization by PARP-inhibitor in prostate cancer

    Köcher, S., Beyer, B., Lange, T., Nordquist, L., Volquardsen, J., Burdak-Rothkamm, S., Schlomm, T., Petersen, C., Rothkamm, K. & Mansour, W. Y., 01.04.2019, In: INT J CANCER. 144, 7, p. 1685-1696 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. 2018
  15. Radiation-induced bystander and systemic effects serve as a unifying model system for genotoxic stress responses

    Burdak-Rothkamm, S. & Rothkamm, K., 21.11.2018, In: MUTAT RES-REV MUTAT. 778, p. 13-22 10 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  16. Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome

    Grupp, K., Hofmann, B., Kutup, A., Bachmann, K., Bogoevski, D., Melling, N., Uzunoglu, F. G., El Gammal, A. T., Koop, C., Simon, R., Steurer, S., Krech, T., Burdak-Rothkamm, S., Jacobsen, F., Sauter, G., Izbicki, J. & Wilczak, W., 12.11.2018, In: BMC CANCER. 18, 1, p. 1106

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model

    Benten, D., Behrang, Y., Unrau, L., Weissmann, V., Wolters-Eisfeld, G., Burdak-Rothkamm, S., Stahl, F. R., Anlauf, M., Grabowski, P., Möbs, M., Dieckhoff, J., Sipos, B., Fahl, M., Eggers, C., Perez, D., Bockhorn, M., Izbicki, J. R., Lohse, A. W. & Schrader, J., 01.03.2018, In: MOL CANCER RES. 16, 3, p. 496-507 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. 2017
  19. High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer

    Burdelski, C., Shihada, R., Hinsch, A., Angerer, A., Göbel, C., Friedrich, E., Hube-Magg, C., Burdak-Rothkamm, S., Kluth, M., Simon, R., Möller-Koop, C., Sauter, G., Büscheck, F., Wittmer, C., Clauditz, T. S., Krech, T., Tsourlakis, M. C., Minner, S., Graefen, M., Schlomm, T., Wilczak, W. & Jacobsen, F., 11.2017, In: PROSTATE. 77, 15, p. 1528-1538 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers

    Person, F., Wilczak, W., Hube-Magg, C., Burdelski, C., Möller-Koop, C., Simon, R., Noriega, M., Sauter, G., Steurer, S., Burdak-Rothkamm, S. & Jacobsen, F., 10.2017, In: TUMOR BIOL. 39, 10, p. 1010428317712166

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer

    Jacobsen, F., Taskin, B., Melling, N., Sauer, C., Wittmer, C., Hube-Magg, C., Kluth, M., Simon, R., Pehrke, D., Beyer, B., Steuber, T., Thederan, I., Sauter, G., Schlomm, T., Wilczak, W., Möller, K., Weidemann, S. A. & Burdak-Rothkamm, S., 26.07.2017, In: BMC CANCER. 17, 1, p. 504

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation

    Schrader, J., Henes, F. O., Perez, D., Burdak-Rothkamm, S., Stein, A., Izbicki, J. R. & Lohse, A. W., 01.04.2017, In: ANN ONCOL. 28, 4, p. 904-905

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  23. 2016
  24. Targeted nanoparticles for tumour radiotherapy enhancement - the long dawn of a golden era?

    Gargioni, E., Schulz, F., Raabe, A., Burdak-Rothkamm, S., Rieckmann, T. & Rothkamm, K., 12.2016, In: ANN TRANSL MED. 4, 24, p. 523

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. 2015
  26. BRCA1, FANCD2 and Chk1 are potential molecular targets for the modulation of a radiation-induced DNA damage response in bystander cells

    Burdak-Rothkamm, S., Rothkamm, K., McClelland, K., Al Rashid, S. T. & Prise, K. M., 28.01.2015, In: CANCER LETT. 356, 2 Pt B, p. 454-61 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma

    Loga, K., Kohlhaussen, J., Burkhardt, L., Simon, R., Steurer, S., Burdak-Rothkamm, S., Jacobsen, F., Sauter, G. & Krech, T., 2015, In: PLOS ONE. 10, 11, p. e0141867

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. 2011
  29. Ionizing radiation-induced DNA strand breaks and γ-H2AXγ-H2AX foci in cells exposed to nitric oxide

    Rothkamm, K. & Burdak-Rothkamm, S., 2011, In: Methods Mol Biol. 704, p. 17-25 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. 2010
  31. Cohesin promotes the repair of ionizing radiation-induced DNA double-strand breaks in replicated chromatin

    Bauerschmidt, C., Arrichiello, C., Burdak-Rothkamm, S., Woodcock, M., Hill, M. A., Stevens, D. L. & Rothkamm, K., 01.2010, In: NUCLEIC ACIDS RES. 38, 2, p. 477-87 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. 2009
  33. New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells

    Burdak-Rothkamm, S. & Prise, K. M., 25.12.2009, In: EUR J PHARMACOL. 625, 1-3, p. 151-5 5 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  34. DNA and chromosomal damage in response to intermittent extremely low-frequency magnetic fields

    Burdak-Rothkamm, S., Rothkamm, K., Folkard, M., Patel, G., Hone, P., Lloyd, D., Ainsbury, L. & Prise, K. M., 31.01.2009, In: MUTAT RES-FUND MOL M. 672, 2, p. 82-9 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. 2008
  36. Oral polio vaccination leads to oligoclonal expansion of TCRBV16+ and TCRBV13+ T cells in the colon of rhesus macaques

    Hörer, S., Burdak-Rothkamm, S., Allers, K., Schneider, T. & Duchmann, R., 12.2008, In: EXP MOL PATHOL. 85, 3, p. 189-95 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. ATM acts downstream of ATR in the DNA damage response signaling of bystander cells

    Burdak-Rothkamm, S., Rothkamm, K. & Prise, K. M., 01.09.2008, In: CANCER RES. 68, 17, p. 7059-65 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. 2007
  39. Cytoplasmic irradiation induces mitochondrial-dependent 53BP1 protein relocalization in irradiated and bystander cells

    Tartier, L., Gilchrist, S., Burdak-Rothkamm, S., Folkard, M. & Prise, K. M., 15.06.2007, In: CANCER RES. 67, 12, p. 5872-9 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. ATR-dependent radiation-induced gamma H2AX foci in bystander primary human astrocytes and glioma cells

    Burdak-Rothkamm, S., Short, S. C., Folkard, M., Rothkamm, K. & Prise, K. M., 15.02.2007, In: ONCOGENE. 26, 7, p. 993-1002 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. 2005
  42. Radiosensitivity of tumor cell lines after pretreatment with the EGFR tyrosine kinase inhibitor ZD1839 (Iressa)

    Burdak-Rothkamm, S., Rübe, C. E., Nguyen, T. P., Ludwig, D., Feldmann, K., Wiegel, T. & Rübe, C., 03.2005, In: STRAHLENTHER ONKOL. 181, 3, p. 197-204 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. 2004
  44. Irradiation induces a biphasic expression of pro-inflammatory cytokines in the lung

    Rübe, C. E., Wilfert, F., Palm, J., König, J., Burdak-Rothkamm, S., Liu, L., Schuck, A., Willich, N. & Rübe, C., 07.2004, In: STRAHLENTHER ONKOL. 180, 7, p. 442-8 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review